Literature DB >> 25829393

Evidence for a link between gut microbiota and hypertension in the Dahl rat.

Blair Mell1, Venkatakrishna R Jala2, Anna V Mathew3, Jaeman Byun3, Harshal Waghulde1, Youjie Zhang1, Bodduluri Haribabu2, Matam Vijay-Kumar4, Subramaniam Pennathur3, Bina Joe5.   

Abstract

The gut microbiota plays a critical role in maintaining physiological homeostasis. This study was designed to evaluate whether gut microbial composition affects hypertension. 16S rRNA genes obtained from cecal samples of Dahl salt-sensitive (S) and Dahl salt-resistant (R) rats were sequenced. Bacteria of the phylum Bacteroidetes were higher in the S rats compared with the R rats. Furthermore, the family S24-7 of the phylum Bacteroidetes and the family Veillonellaceae of the phylum Firmicutes were higher in the S rats compared with the R rats. Analyses of the various phylogenetic groups of cecal microbiota revealed significant differences between S and R rats. Both strains were maintained on a high-salt diet, administered antibiotics for ablation of microbiota, transplanted with S or R rat cecal contents, and monitored for blood pressure (BP). Systolic BP of the R rats remained unaltered irrespective of S or R rat cecal transplantation. Surprisingly, compared with the S rats given S rat cecal content, systolic BP of the S rats given a single bolus of cecal content from R rats was consistently and significantly elevated during the rest of their life, and they had a shorter lifespan. A lower level of fecal bacteria of the family Veillonellaceae and increased plasma acetate and heptanoate were features associated with the increased BP observed in the S rats given R rat microbiota compared with the S rats given S rat microbiota. These data demonstrate a link between microbial content and BP regulation and, because the S and R rats differ in their genomic composition, provide the necessary basis to further examine the relationship between the host genome and microbiome in the context of BP regulation in the Dahl rats.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  SCFA; gut; metabolic; metabolomics; microbial

Mesh:

Substances:

Year:  2015        PMID: 25829393      PMCID: PMC4451389          DOI: 10.1152/physiolgenomics.00136.2014

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  57 in total

1.  Hypertensive renal injury is associated with gene variation affecting immune signaling.

Authors:  Michael C Braun; Stacy M Herring; Nisha Gokul; Monique Monita; Rebecca Bell; Yaming Zhu; Manuel L Gonzalez-Garay; Scott E Wenderfer; Peter A Doris
Journal:  Circ Cardiovasc Genet       Date:  2014-11-03

Review 2.  The microbiome and obesity-an established risk for certain types of cancer.

Authors:  Connie J Rogers; Kumble Sandeep Prabhu; Matam Vijay-Kumar
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

3.  Water and ion handling in the rat cecum.

Authors:  E Escobar; C Ibarra; E Todisco; M Parisi
Journal:  Am J Physiol       Date:  1990-11

4.  Reshaping the gut microbiome with bacterial transplantation and antibiotic intake.

Authors:  Chaysavanh Manichanh; Jens Reeder; Prudence Gibert; Encarna Varela; Marta Llopis; Maria Antolin; Roderic Guigo; Rob Knight; Francisco Guarner
Journal:  Genome Res       Date:  2010-08-24       Impact factor: 9.043

5.  Increased expression of NAD(P)H oxidase subunit p67(phox) in the renal medulla contributes to excess oxidative stress and salt-sensitive hypertension.

Authors:  Di Feng; Chun Yang; Aron M Geurts; Terry Kurth; Mingyu Liang; Jozef Lazar; David L Mattson; Paul M O'Connor; Allen W Cowley
Journal:  Cell Metab       Date:  2012-02-08       Impact factor: 27.287

Review 6.  The core gut microbiome, energy balance and obesity.

Authors:  Peter J Turnbaugh; Jeffrey I Gordon
Journal:  J Physiol       Date:  2009-06-02       Impact factor: 5.182

7.  Gut microbiota from twins discordant for obesity modulate metabolism in mice.

Authors:  Vanessa K Ridaura; Jeremiah J Faith; Federico E Rey; Jiye Cheng; Alexis E Duncan; Andrew L Kau; Nicholas W Griffin; Vincent Lombard; Bernard Henrissat; James R Bain; Michael J Muehlbauer; Olga Ilkayeva; Clay F Semenkovich; Katsuhiko Funai; David K Hayashi; Barbara J Lyle; Margaret C Martini; Luke K Ursell; Jose C Clemente; William Van Treuren; William A Walters; Rob Knight; Christopher B Newgard; Andrew C Heath; Jeffrey I Gordon
Journal:  Science       Date:  2013-09-06       Impact factor: 47.728

Review 8.  Gut microbes and host physiology: what happens when you host billions of guests?

Authors:  Jennifer L Pluznick
Journal:  Front Endocrinol (Lausanne)       Date:  2014-06-13       Impact factor: 5.555

9.  Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets.

Authors:  Trond Ulven
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-02       Impact factor: 5.555

Review 10.  The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome.

Authors:  Parth J Parekh; Eli Arusi; Aaron I Vinik; David A Johnson
Journal:  Front Endocrinol (Lausanne)       Date:  2014-04-07       Impact factor: 5.555

View more
  141 in total

Review 1.  Immune Mechanisms in Arterial Hypertension.

Authors:  Ulrich Wenzel; Jan Eric Turner; Christian Krebs; Christian Kurts; David G Harrison; Heimo Ehmke
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

2.  The Gut Microbial Metabolite Trimethylamine N-Oxide and Hypertension Risk: A Systematic Review and Dose-Response Meta-analysis.

Authors:  Xinyu Ge; Liang Zheng; Rulin Zhuang; Ping Yu; Zhican Xu; Guanya Liu; Xiaoling Xi; Xiaohui Zhou; Huimin Fan
Journal:  Adv Nutr       Date:  2020-01-01       Impact factor: 8.701

3.  Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study.

Authors:  Rabi Yacoub; Girish N Nadkarni; Daniel I McSkimming; Lee D Chaves; Sham Abyad; Mark A Bryniarski; Amanda M Honan; Shruthi A Thomas; Madan Gowda; John C He; Jaime Uribarri
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-12

Review 4.  Microbial Short-Chain Fatty Acids and Blood Pressure Regulation.

Authors:  Jennifer L Pluznick
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

Review 5.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

Review 6.  Genomic Determinants of Hypertension With a Focus on Metabolomics and the Gut Microbiome.

Authors:  Panayiotis Louca; Cristina Menni; Sandosh Padmanabhan
Journal:  Am J Hypertens       Date:  2020-05-21       Impact factor: 2.689

Review 7.  Report of the National Heart, Lung, and Blood Institute Working Group on Hypertension: Barriers to Translation.

Authors:  Curt D Sigmund; Robert M Carey; Lawrence J Appel; Donna K Arnett; Hayden B Bosworth; William C Cushman; Zorina S Galis; Melissa Green Parker; John E Hall; David G Harrison; Alicia A McDonough; Holly L Nicastro; Suzanne Oparil; John W Osborn; Mohan K Raizada; Jacqueline D Wright; Young S Oh
Journal:  Hypertension       Date:  2020-02-17       Impact factor: 10.190

8.  Attenuation of Microbiotal Dysbiosis and Hypertension in a CRISPR/Cas9 Gene Ablation Rat Model of GPER1.

Authors:  Harshal Waghulde; Xi Cheng; Sarah Galla; Blair Mell; Jingwei Cai; Shondra M Pruett-Miller; Guillermo Vazquez; Andrew Patterson; Matam Vijay Kumar; Bina Joe
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

9.  Altered microRNA regulation of short chain fatty acid receptors in the hypertensive kidney is normalized with hydrogen sulfide supplementation.

Authors:  Gregory J Weber; Jaleyea Foster; Sathnur B Pushpakumar; Utpal Sen
Journal:  Pharmacol Res       Date:  2018-06-15       Impact factor: 7.658

10.  Prebiotics, Probiotics, and Acetate Supplementation Prevent Hypertension in a Model of Obstructive Sleep Apnea.

Authors:  Bhanu P Ganesh; James W Nelson; Joshua R Eskew; Arunkumar Ganesan; Nadim J Ajami; Joseph F Petrosino; Robert M Bryan; David J Durgan
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.